Why Kamala's Interview With a Muslim Influencer Went Off the Rails
One Dearborn Voter's Damning Observation About Kamala
This Video Out of California Shows Why Voter ID Laws Are Necessary
The Liberal Media Is Seething Right Now Heading Into Election Day
Is It Too Early to Talk 2028?
Trump Unveils New Proposal to Tackle Border Crisis
The NYT Has a Big Problem on Its Hands Heading Into Election Day
RFK Jr.'s Final Pitch: 'Do NOT Vote for Me'
Go Vote: GOP Senator Predicts What the Country Would Look Like After the...
Trump's Closing Message to Voters
Do the Unrighteous Now Outnumber the Righteous in America?
Voter Turnout and Ballot Completion Is Everything
Texas Tells DOJ Election Monitors to Pound Sand
The Elites Are About to Hand Trump a Second Term
Kamala Harris’ Energy Policies Are More Extreme and Harmful Than Biden’s
Tipsheet

Johnson & Johnson Vaccine Gets Thumbs Up from FDA Staff

AP Photo/Mel Evans

Staff for the U.S. Food and Drug Administration found that the Johnson & Johnson coronavirus vaccine is safe and effective, meaning it may soon be the third vaccine to get the agency's approval. What makes this news stand out is that unlike the vaccines from Pfizer-BioNTech and Moderna, the Johnson & Johnson vaccine requires only a single dose.

Advertisement

While the Johnson & Johnson jab showed 66% effectiveness overall as opposed to the other vaccines, which have efficacy rates in the 90s, the company notes that their vaccine was shown to prevent 100% of hospitalizations after performing a clinical study of around 44,000 patients in the U.S., South Africa and other countries.

J&J submitted its Covid vaccine data to the FDA on Feb. 4. The vaccine’s level of protection varied by region, J&J said, with the shot demonstrating 66% effectiveness overall, 72% in the United States, 66% in Latin America and 57% in South Africa, where the B.1.351 variant is rapidly spreading. However, the FDA staff documents show the vaccine was 64% effective in South Africa after about a month. The company said the vaccine prevented 100% of hospitalizations and deaths. (CNBC)

Advertisement

The FDA’s Vaccines and Related Biological Products Advisory Committee will meet on Friday to discuss Johnson & Johnson's emergency authorization request, meaning we could get word of an approval as early as this weekend.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement